As legal cannabis goes mainstream, it’s finding its way into a good deal of medical, beauty, and even recreational products. Along the way, it’s revolutionizing the way medical issues are being treated all over the world. Some of the most well-known chemicals are already helping to treat epilepsy, neuropsychiatric disorders, cancer, chronic pain, and anxiety, for example.
Helping even more, Senate Democrats could make cannabis reform a top priority in 2021. “We are committed to working together to put forward and advance comprehensive cannabis reform legislation that will not only turn the page on this sad chapter in American history, but also undo the devastating consequences of these discriminatory policies,” said Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ), as quoted by Marijuana Moment.
That Could Help Drive Big Interest in Cannabis Companies
Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF)(XFRA:A2QJAJ) and Canada House Wellness Group (CSE: CHV), a fully integrated medical cannabis company, just announced they have entered into a Cannabis 2.0 distribution agreement. Under the terms of the Agreement, Canada House's wholly owned subsidiary, Abba Medix Corp. will distribute Pure Extracts' line of concentrate products through its established provincial distribution channels.
"We've been extremely impressed with the Pure Extracts team and the brand presence they have established, particularly in the western provinces, and are looking forward to supporting their commercialization efforts in a mutually beneficial way," commented Chris Churchill-Smith, Canada House CEO.
Pure Extracts’ CEO, Ben Nikolaevsky, added, "This Agreement allows us to quickly and efficiently get our outstanding line of full spectrum oil vape and edible products to retail buyers across Canada while our Sales Amendment application is being processed by Health Canada."
Medical Cannabis Could be a $53.35 Billion Market by 2025, Says Market Research Future
Other than Pure Extracts Technologies Corp., look at Aleafia Health Inc. (TSX:AH)(OTC:ALEAF).
The company just announced it will commence cannabis exports to the Israeli medical cannabis market. The Company signed a binding letter of intent with Equinox International Ltd., a licensed British medical cannabis company with operations in the Israeli market. Under the LOI, Equinox has committed to purchasing approximately 1,400 kg of dried flower in 2021. The first shipment to Equinox is expected to occur in Q1 2021 pending receipt of necessary import and export permits and completion of Aleafia’s cultivation cycle. Permit applications have already been submitted and will mark the first export of EU GACP-compliant dried flower grown at Aleafia’s Niagara Greenhouse facility.
Tilray Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, announced it has agreed with Worldpharma Biotech through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. to export Good Manufacturing Processes (GMP) certified medical cannabis from Portugal to Spain. The shipment marks the first medical cannabis import into Spain by Worldpharma and the 17th country to receive Tilray medical cannabis worldwide. The Agencia Española de Medicamentos y Productos Sanitorios (AEMPS), Spain’s food and drug administration, has approved Worldpharma to import Tilray’s GMP-certified medical cannabis as raw material from its Portugal facility to Spain.
Aphria Inc. (TSX:APHA)(NASDAQ:APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their best life, announced the addition of topicals to its award winning adult-use brand Solei® . Known for its occasion-based offerings, our Solei® Topicals will join a range of other formats currently available, including whole dried flower and pre-rolls, smoke-free oils, oral sprays, soft gels, and vapes. Solei® is the first brand from Aphria’s portfolio to enter the topicals market with its lineup including three of its popular Moments: Unplug (Lavender) , Balance (Orange Citrus) , Free (Cucumber Mint) and Free Unscented . Solei® Topicals have been carefully formulated to provide consumers with the highest potency topical currently available in the Canadian market (500mg of cannabinoid per container) and a superior texture comparable to a premium non-infused cream – rich to the touch.
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Pure Extracts Technologies Corp. by a third party. We own ZERO shares of Pure Extracts Technologies Corp. Please click here for full disclaimer.
Contact Information:
2818047972
ty@LifeWaterMedia.com